About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
A four-compartment pharmacokinetic model that describes the disposition of losartan and E-3174 (Karatza and Karalis, 2020). The main objective of this model is to describe the secondary maxima observe.
Manifest
{
"io": {
"inputs": [
{
"name": "losartan_oral_dose",
"label": "Losartan Oral Dose",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.losartan_oral_dose"
},
{
"name": "cyp2c9_metabolism_start_time",
"label": "CYP2C9 Metabolism Start Time",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.cyp2c9_metabolism_start_time"
},
{
"name": "initial_losartan_stomach",
"label": "Initial Losartan Stomach",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.initial_losartan_stomach"
}
],
"outputs": [
{
"name": "state",
"label": "Tracked source state",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.state"
},
{
"name": "summary",
"label": "Simulation summary",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.summary"
},
{
"name": "species_labels",
"label": "Observable labels",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.species_labels"
},
{
"name": "losartan_cellular_compartment",
"label": "Losartan Cellular Compartment",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.losartan_cellular_compartment"
},
{
"name": "losartan_intracellular",
"label": "Losartan Intracellular",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.losartan_intracellular"
},
{
"name": "losartan_outflow",
"label": "Losartan Outflow",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.losartan_outflow"
},
{
"name": "losartan_portal_compartment",
"label": "Losartan Portal Compartment",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.losartan_portal_compartment"
},
{
"name": "losartan_stomach",
"label": "Losartan Stomach",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.losartan_stomach"
},
{
"name": "e3174_outflow",
"label": "E3174 Outflow",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.e3174_outflow"
},
{
"name": "e3174_cellular_compartment",
"label": "E3174 Cellular Compartment",
"maps_to": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.e3174_cellular_compartment"
}
]
},
"tags": [
"pharmacology",
"metabolism",
"cyp-metabolism",
"pharmacokinetics",
"cardiovascular",
"sbml",
"tellurium",
"faithful",
"biomodels_ebi"
],
"title": "KaratzaKaralis2020 - CYP mediated losartan metabolism Lab",
"models": [
{
"path": "models/core",
"alias": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model",
"parameters": {
"model_path": "data/MODEL2412180001.xml",
"integration_step": 0.1
}
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model_state"
],
"from": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.state"
},
{
"to": [
"visualisation.pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model_summary"
],
"from": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.summary"
},
{
"to": [
"visualisation.pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model_species_labels"
],
"from": "pharmacology_sbml_karatzakaralis2020_cyp_mediated_losartan_metabol_model2412180001_model.species_labels"
}
],
"package": "karatzakaralis2020-losartan-cyp-metabolism",
"runtime": {
"duration": 24,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "A four-compartment pharmacokinetic model that describes the disposition of losartan and E-3174 (Karatza and Karalis, 2020). The main objective of this model is to describe the secondary maxima observe.",
"schema_version": "2.0"
}Runtime
Duration24
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagekaratzakaralis2020-losartan-cyp-metabolism
Created2026-05-16
Updated2026-06-13
pharmacologymetabolismcyp-metabolismpharmacokineticscardiovascularsbmltelluriumfaithfulbiomodels_ebivisualisationother